How long should I wait after discontinuing atomoxetine (Strattera) before starting lisdexamfetamine (Vyvanse)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Switching from Strattera (Atomoxetine) to Vyvanse (Lisdexamfetamine)

You can start Vyvanse immediately after stopping Strattera without any required waiting period. 1, 2

No Washout Period Needed

  • Atomoxetine can be discontinued abruptly without tapering, and there is no evidence of rebound symptoms or discontinuation syndrome when stopping treatment. 1, 3, 2

  • No waiting period is required between stopping atomoxetine and starting lisdexamfetamine because atomoxetine is not a monoamine oxidase inhibitor (MAOI) and does not have the same drug interaction concerns. 1

  • The FDA label for Strattera specifically contraindicates use with MAOIs and requires a 2-week washout period only for MAOIs—not for stimulants like Vyvanse. 1

Safety of Immediate Transition

  • Atomoxetine and stimulants can even be co-administered during a switching period without undue concern for adverse cardiovascular effects, though blood pressure and heart rate monitoring is necessary. 3

  • Studies demonstrate that discontinuation of atomoxetine is well-tolerated with low incidence of discontinuation-emergent adverse events, and no statistically significant differences compared to placebo. 2

  • Most common adverse events from atomoxetine resolve within 3 to 53 days after discontinuation, with blood pressure and heart rate returning to baseline upon stopping the medication. 4

Clinical Approach to the Switch

  • Start lisdexamfetamine at standard initial dosing (typically 30 mg once daily in the morning) on the day after stopping atomoxetine, or even the same day if clinically appropriate. 3

  • Monitor blood pressure and heart rate during the transition, as both medications can affect cardiovascular parameters, though atomoxetine's effects resolve after discontinuation. 4, 3

  • Allow 6-8 weeks to fully evaluate the efficacy and tolerability of lisdexamfetamine after the switch, as this is the recommended trial period for ADHD medications. 3

  • Be aware that approximately 75% of patients who respond to one ADHD medication will also respond to another, though individual responses vary. 3

Related Questions

For Strattera (atomoxetine) taken at 50 mg daily by mouth, is a taper required when discontinuing?
How can I safely discontinue atomoxetine (Strattera) and start mixed‑amphetamine (Adderall) therapy?
Does Strattera (atomoxetine) need to be tapered when discontinuing a 40 mg dose?
What is the recommended medication regimen, including formulation and dosing, for restarting atomoxetine (Strattera) and escitalopram (Lexapro) in a 9‑year‑old girl with ADHD and depressive symptoms related to bullying who previously could not tolerate the capsule form and experienced stomach discomfort with escitalopram?
A 6-year-old child taking atomoxetine (Strattera) 50 mg daily is not showing improvement; what is the next step in management?
What is the incubation period for norovirus?
Can you explain the kidney-to-body-height ratio (KBR) in detail?
In a 35‑year‑old obese male with a three‑day history of a painful, tender, erythematous, flat area on the medial ankle approximately 8 cm proximal to the medial malleolus that worsens with dorsiflexion and has no range‑of‑motion limitation after playing badminton, what is the most likely diagnosis and what are the appropriate next steps in management?
What is the recommended prednisone dose for induction therapy in acute lymphoblastic leukemia?
What are the possible causes and recommended management for a 36-year-old monogamous male presenting with strong-smelling urine and mild dysuria despite negative urine culture and STI tests?
When should oral potassium chloride be given instead of intravenous potassium chloride?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.